Akemi Sakamoto

4.3k total citations · 1 hit paper
78 papers, 3.5k citations indexed

About

Akemi Sakamoto is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Akemi Sakamoto has authored 78 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 20 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Akemi Sakamoto's work include T-cell and B-cell Immunology (30 papers), Immune Cell Function and Interaction (28 papers) and Immunotherapy and Immune Responses (10 papers). Akemi Sakamoto is often cited by papers focused on T-cell and B-cell Immunology (30 papers), Immune Cell Function and Interaction (28 papers) and Immunotherapy and Immune Responses (10 papers). Akemi Sakamoto collaborates with scholars based in Japan, United States and China. Akemi Sakamoto's co-authors include Philippa Marrack, Masaaki Murakami, John W. Kappler, Chia‐Chi Ku, Masahiko Hatano, Takeshi Tokuhisa, Masafumi Arima, Hirohito Ichii, Jeremy Bender and Takayuki Sumida and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Akemi Sakamoto

75 papers receiving 3.5k citations

Hit Papers

Control of Homeostasis of CD8 + Memory T Cells by Opposin... 2000 2026 2008 2017 2000 200 400 600

Peers

Akemi Sakamoto
Akemi Sakamoto
Citations per year, relative to Akemi Sakamoto Akemi Sakamoto (= 1×) peers Girdhari Lal

Countries citing papers authored by Akemi Sakamoto

Since Specialization
Citations

This map shows the geographic impact of Akemi Sakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akemi Sakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akemi Sakamoto more than expected).

Fields of papers citing papers by Akemi Sakamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akemi Sakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akemi Sakamoto. The network helps show where Akemi Sakamoto may publish in the future.

Co-authorship network of co-authors of Akemi Sakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Akemi Sakamoto. A scholar is included among the top collaborators of Akemi Sakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akemi Sakamoto. Akemi Sakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumagai, T., Arifumi Iwata, Atsushi Okabe, et al.. (2024). A distal enhancer of GATA3 regulates Th2 differentiation and allergic inflammation. Proceedings of the National Academy of Sciences. 121(27). e2320727121–e2320727121. 6 indexed citations
2.
Toda, Yosuke, Arifumi Iwata, T. Kumagai, et al.. (2024). Stage-specific GATA3 induction promotes ILC2 development after lineage commitment. Nature Communications. 15(1). 5610–5610. 8 indexed citations
3.
Yoshifuji, Ayumi, Shinji Nakahara, Akemi Sakamoto, et al.. (2023). Managing Interhospital Referrals During a COVID-19 Patient Surge in Japan: Creating Available Beds by Exchanging Patients. Health Security. 21(3). 165–175. 1 indexed citations
4.
Eguchi, Akifumi, Akemi Sakamoto, Xiayun Wan, et al.. (2022). Effects of splenectomy on skin inflammation and psoriasis-like phenotype of imiquimod-treated mice. Scientific Reports. 12(1). 14738–14738. 26 indexed citations
5.
Zhang, Kai, Chun Yang, Lijia Chang, et al.. (2020). Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1. Translational Psychiatry. 10(1). 32–32. 94 indexed citations
6.
Suzuki, Kotaro, Kazuyuki Meguro, Shigeru Tanaka, et al.. (2016). IκBNS enhances follicular helper T-cell differentiation and function downstream of ASCl2. Journal of Allergy and Clinical Immunology. 140(1). 288–291.e8. 11 indexed citations
7.
Miyauchi, Yoshiteru, Ken Ninomiya, Hiroya Miyamoto, et al.. (2010). The Blimp1–Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. The Journal of Experimental Medicine. 207(4). 751–762. 161 indexed citations
8.
Murakami, Masaaki, Chika Kitabayashi, Naoko Ueda, et al.. (2007). Homeostatically proliferating CD4+ T cells are involved in the pathogenesis of an Omenn syndrome murine model. Journal of Clinical Investigation. 117(5). 1270–1281. 58 indexed citations
9.
Sakamoto, Akemi, et al.. (2007). A role for Bcl6 in sequential class switch recombination to IgE in B cells stimulated with IL-4 and IL-21. Molecular Immunology. 45(5). 1337–1345. 20 indexed citations
10.
Tada, Motohisa, Fumio Imazeki, Kenichi Fukai, et al.. (2007). Procaine inhibits the proliferation and DNA methylation in human hepatoma cells. Hepatology International. 1(3). 355–364. 56 indexed citations
11.
Ichii, Hirohito, Akemi Sakamoto, Masafumi Arima, et al.. (2007). Bcl6 is essential for the generation of long-term memory CD4+ T cells. International Immunology. 19(4). 427–433. 65 indexed citations
12.
Arima, Masafumi, Eggi Arguni, Seiji Okada, et al.. (2005). A Role for c- fos /Activator Protein 1 in B Lymphocyte Terminal Differentiation. The Journal of Immunology. 174(12). 7703–7710. 64 indexed citations
13.
Arima, Masafumi, Lisa Fujimura, Haifeng Li, et al.. (2005). Bcl6 regulates Th2 type cytokine productions by mast cells activated by FcɛRI/IgE cross-linking. Molecular Immunology. 42(12). 1453–1459. 2 indexed citations
14.
Asari, Sadaki, Akemi Sakamoto, Seiji Okada, et al.. (2005). Abnormal erythroid differentiation in neonatal bcl-6-deficient mice. Experimental Hematology. 33(1). 26–34. 19 indexed citations
15.
Ichii, Hirohito, Akemi Sakamoto, Yoshikazu Kuroda, & Takeshi Tokuhisa. (2004). Bcl6 Acts as an Amplifier for the Generation and Proliferative Capacity of Central Memory CD8+ T Cells. The Journal of Immunology. 173(2). 883–891. 125 indexed citations
16.
Yamashita, Kimihiro, Akemi Sakamoto, Masafumi Arima, et al.. (2004). c-fos Overexpression in splenic B cells augments development of marginal zone B cells. Molecular Immunology. 42(5). 617–625. 8 indexed citations
17.
Arima, Masafumi, N Tsuruoka, Seiji Okada, et al.. (2003). Bcl6 Is a Transcriptional Repressor for the IL-18 Gene. The Journal of Immunology. 171(1). 426–431. 44 indexed citations
18.
Sakamoto, Akemi, et al.. (1994). Development of an instrument to assess quality of life in children with epilepsy and learning disability. Epilepsia. 35(7). 47. 13 indexed citations
19.
Sumida, Takayuki, Akemi Sakamoto, Takashi Namekawa, et al.. (1994). Prevention of insulitis and diabetes in Β2-microglobulin-deficjent non-obese diabetic mice. International Immunology. 6(9). 1445–1449. 73 indexed citations
20.
Sakamoto, Akemi, Takayuki Sumida, Toshiro Maeda, et al.. (1992). T cell receptor vβ repertoire of double‐negative α/β t cells in patients with systemic sclerosis. Arthritis & Rheumatism. 35(8). 944–948. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026